[1] |
Fenoglio LM, Severini S, Ferrigno D, et al. Primary hepatic carcinoid: a case report and literature review[J]. World J Gastroenterol,2009, 15(19):2418-2422.
|
[2] |
Edmondson HA, National Research Council, Subcommittee on Oncology. Tumors of the liver and intrahepatic bile ducts (atlas of tumor pathology)[M].Washington: Armed Forces Institute of Pathology,1958.
|
[3] |
Park CH, Chung JW, Jang SJ, et al. Clinical features and outcomes of primary hepatic neuroendocrine carcinomas[J]. J Gastroenterol Hepatol, 2012,27(8):1306-1311.
|
[4] |
Wang LM, An SL, Wu JX. Diagnosis and therapy of primary hepatic neuroendocrine carcinoma: clinical analysis of 10 cases[J]. Asian Pac J Cancer Prev, 2014, 15(6):2541-2546.
|
[5] |
Lambrescu IM, Martin S, Cima L, et al. Primary hepatic neuroendocrine tumor after 4 years tumor-free follow-up[J]. J Gastrointestin Liver Dis, 2015, 24(2): 241-244.
|
[6] |
Sotiropoulos GC, Charalampoudis P, Delladetsima I, et al. Surgery for giant primary neuroendocrine carcinoma of the liver[J].J Gastrointest Surg, 2014, 18(4): 839-841.
|
[7] |
Bosman F, Carneiro F. World Health Organization classification of tumours, pathology and genetics of tumours of the digestive system[M]. Lyon: IARC Press, 2010.
|
[8] |
Knox CD, Anderson CD, Lamps LW, et al. Long-term survival after resection for primary hepatic carcinoid tumor[J]. Ann Surg Oncol, 2003, 10(10):1171-1175.
|
[9] |
朱雄增.胃肠胰神经内分泌肿瘤新分类的临床意义[J].中华胃肠外科杂志,2013,16(1):12-14.
|
[10] |
Vinik AI, Chaya C. Clinical presentation and diagnosis of neuroendocrine tumors[J]. Hematol Oncol Clin North Am, 2016, 30(1):21-48.
|
[11] |
Fraenkel M, Faggiano A, Valk GD. Epidemiology of neuroendocrine tumors[J]. Front Horm Res, 2015(44):1-23.
|
[12] |
Camargo ÉS, Viveiros Mde M, Corrêa Neto IJ, et al. Primary hepatic carcinoid tumor: case report and literature review[J]. Einstein, 2014, 12(4):505-508.
|
[13] |
Jia C, Zhang Y, Xu J, et al. Experience in primary hepatic neuroendocrine tumor[J]. Turk J Gastroenterol, 2012, 23 (5):546-551.
|
[14] |
Quartey B. Primary hepatic neuroendocrine tumor: what do we know now? [J]. World J Oncol, 2011, 2(5):209-216.
|
[15] |
Hallet J, Law CH, Cukier M, et al. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes[J]. Cancer, 2015, 121(4): 589-597.
|
[16] |
Lin CW, Lai CH, Hsu CC, et al. Primary hepatic carcinoid tumor: a case report and review of the literature[J]. Cases J, 2009, 2(1):90.
|
[17] |
张文书,赵婧,纪元,等.肝原发性与转移性神经内分泌肿瘤的临床病理分析[J].中华肝胆外科杂志,2012,18(3):161-165.
|
[18] |
Pilichowska M, Kimura N, Ouchi A, et al. Primary hepatic carcinoid and neuroendocrine carcinoma: clinicopathological and immunohistochemical study of five cases[J]. Pathol Int, 1999, 49(4):318-324.
|
[19] |
Kellock T, Tuong B, Harris AC, et al. Diagnostic imaging of primary hepatic neuroendocrine tumors: a case and discussion of the literature[J]. Case Rep Radiol, 2014:156491.
|
[20] |
Dala R, Shoosmith J, Lilenbaum R, et al. Primary hepatic neuroendocrine carcinoma: an underdiagnosed entity[J]. Ann Diagn Pathol, 2006, 10(1):28-31.
|
[21] |
Hwang S, Lee YJ, Lee SG, et al. Surgical treatment of primary neuroendocrine tumors of the liver[J]. J Gastrointest Surg, 2008, 12(4):725-730.
|
[22] |
Skagias L, Vasou O, Ntinis A, et al. Primary hepatic neuroendocrine tumor with exophytic growth: report of a case with diagnosis by fine needle aspiration biopsy[J]. Acta Cytol, 2010, 54(2):202-204.
|
[23] |
Yalav O, Ülkü A, Akçam TA, et al. Primary hepatic neuroendocrine tumor: five cases with different preoperative diagnoses[J]. Turk J Gastroenterol, 2012, 23(3):272-278.
|
[24] |
Iwao M, Nakamuta M, Enjoji M, et al. Primary hepatic carcinoid tumor: case report and review of 53 cases[J]. Med Sci Monit, 2001, 7(4):746-750.
|
[25] |
Taner T, Atwell TD, Zhang L, et al. Adjunctive radiofrequency ablation of metastatic neuroendocrine cancer to the liver complements surgical resection[J]. HPB, 2013, 15(3):190-195.
|
[26] |
Wängberg B, Nilsson O, Johanson V, et al. Somatostatin receptors in the diagnosis and therapy of neuroendocrine tumor[J]. Oncologist, 1997, 2(1):50-58.
|
[27] |
Alagusundaramoorthy SS, Gedaly R. Role of surgery and transplantation in the treatment of hepatic metastases from neuroendocrine tumor[J]. World J Gastroenterol, 2014, 20(39):14348-14358.
|
[28] |
Mazzaferro V, Pulvirenti A, Coppa J. Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation?[J].J Hepatol, 2007, 47(4):460-466.
|
[29] |
Olausson M, Friman S, Herlenius G, et al. Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors[J]. Liver Transpl, 2007, 13(3):327-333.
|
[30] |
Gedaly R, Daily MF, Davenport D, et al. Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database[J]. Arch Surg, 2011, 146 (8):953-958.
|